|
|
|
|
Vol. 56, Issue 1, 91-101, July 1999
in 3T3-L1
Cells
Department of Environmental Toxicology and the Center for Environmental Health Sciences, University of California, Davis, California
| |
Summary |
|---|
|
|
|---|
The effects of selected chlorinated cyclodiene pesticides on the
adipocyte differentiation process were examined using the 3T3-L1
adipocyte model in vitro. Endrin was found to cause a dose-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. Aldrin and
dieldrin were less potent than endrin in interfering with the
adipogenic process. Endrin's inhibitory effect was effective only when
the pesticide was present in the medium during the first 48 h
after exposure of 3T3-L1 cells to adipogenic inducers. Immunoblots analysis revealed that endrin caused a dose-dependent, selective inhibition of the intracellular levels of CCAAT enhancer binding protein (C/EBP)
without altering the expression patterns of C/EBP
or C/EBP
along the differentiation. Supershift analysis showed that
DNA-binding capacity of C/EBP
was affected most by endrin treatment.
Endrin also caused a decrease in the elevation of the adipogenic factor
peroxisome proliferator-activated receptor (PPAR)
elicited by the
adipogenic inducers. However, the cotreatment with troglitazone, a
thiazolidinedione known to activate PPAR
, did not suppress the
antiadipogenic action of endrin, indicating that its direct action site
is not PPAR
receptor. Endrin also altered the pattern of activation
of nuclear factor-
B, a factor activated by
12-O-tetradecanoylphorbol-13-acetate and tumor necrosis factor-
, which are known to interfere with adipocyte
differentiation. Thus, endrin inhibited the normal decrease in nuclear
factor-
B-DNA binding observed as cells are acquiring the adipocyte
phenotype at a late stage of differentiation. Our results suggest that
endrin inhibits adipocyte differentiation through the specific
suppression of C/EBP
.
| |
Introduction |
|---|
|
|
|---|
The
polyhalogenated cyclic hydrocarbons include a variety of pesticides,
such as endrin and contaminants of pesticides like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Hassoun and
Stohs, 1996a
). It is well known that many of environmental xenobiotics are stable lipophilic compounds; therefore, adipose tissue constitutes the main place for their accumulation in the organisms. It must be
emphasized that adipose tissues are not a mere inert storage site for
those xenobiotics; rather, several recent studies have shown that they
are biochemically very active tissues responding to many hormonal,
nutritional, inflammatory, and growth-regulating factors (Spiegelman,
1998
). Because of this, adipocytes are a major target for the toxic
actions of these lipophilic chemicals.
Several studies performed by our group have shown that TCDD and related
compounds cause major alterations of the function of adipose tissue
(Enan et al., 1992
; Liu and Matsumura, 1995
), as well as adipogenic
cell lines in culture, including the suppression of adipocyte
differentiation (Phillips et al., 1995
).
Endrin
(1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4
-5,6,7,8,8
-octahydroendo,
endo-1,4:5,8-dimethano-naphthalene) is a highly toxic chlorinated
cyclodiene pesticide. As reported by Hassoun and Stohs (1996a)
,
endrin's toxic effects in laboratory animals are similar in some
aspects to those caused by TCDD, including hepatotoxicity, induction of
drug-metabolizing enzymes, thymic hypoplasia, weight loss, and,
eventually, death. Several studies have given strong evidence that free
radical-mediated lipid peroxidation is contributing to the toxicity of
TCDD and endrin (Bagchi and Stohs, 1993
; Hassoun and Stohs,
1996b
). A recent study has shown that the enhanced production of
reactive species observed after in vitro and in vivo endrin treatment
may interfere with the protein kinase (PK)C signaling pathway. It has
been suggested that this could lead to altered cell proliferation and
differentiation (Bagchi et al., 1995
, 1997
).
Taking into account that cyclodiene pesticides accumulate mainly in
adipose tissue and the adipocyte differentiation process plays an
important role in obesity and other metabolic diseases, we considered
it to be extremely worthwhile to determine the effects of these
xenobiotics on this differentiation process. The studies were performed
using 3T3-L1 cells, which have been shown to be a very adequate, yet
convenient cell culture model for the investigation of the program of
adipose differentiation (Green and Kehinde, 1974
).
Adipocyte differentiation is a complex process that is mainly
controlled by two families of transcription factors: the CCAAT enhancer
binding proteins (C/EBPs) and peroxisome proliferator-activated receptor (PPARs). Several members of the C/EBP family of basic leucine
zipper proteins have been identified (Cao et al., 1991
). Several
reports have provided strong evidence that C/EBP
plays an important
role in the transcriptional control of the adipocyte differentiation
process. In addition, binding sites for C/EBP
have been identified
in the promoters of several adipocyte-specific genes, such as aP2
(reviewed by MacDougald and Lane, 1995
). C/EBP
and C/EBP
, which
are induced significantly earlier than C/EBP
in the time course of
differentiation, also play a role in the control of adipogenesis (Wu et
al., 1995
, 1996
).
PPAR
is the only member of the PPAR family that has been shown to be
expressed at high levels specifically in adipose tissue. Like C/EBP
,
the retroviral expression of PPAR
is sufficient to induce the
conversion of several fibroblast cell lines into adipocytes (Tontonoz
et al., 1994
). It has been shown that the simultaneous coexpression of
PPAR
and C/EBP
in fibroblast has a synergistic effect on the
induction of adipocyte conversion process.
To determine the mechanism or mechanisms by which endrin and its
analogs were interfering with the adipocyte differentiation process,
its effects on the expression of the different C/EBP proteins as well
as PPAR
were studied. We also investigated the effects of endrin on
the capacity of the different C/EBPs to bind to a
32P-labeled oligonucleotide containing the C/EBP
response element.
Adipocyte differentiation can be affected by a large number of mitogens
and growth factors. Tumor necrosis factor (TNF)
and other cytokines
have also been shown to be potent inhibitors of adipogenesis (Zhang et
al., 1996
). Nuclear factor-
B (NF-
B) is a transcription factor
that specifically carries the TNF
message (Beg et al., 1993
).
12-O-Tetradecanoylphorbol-13-acetate (TPA) treatment is
known to increase the nuclear level of NF-
B by increasing PKC
activity in cytosol (Steffan et al., 1995
). As previously indicated,
endrin has been shown to induce an increase in PKC activity, which
could lead to an activation of NF-
B transcriptional activity. To
test this possibility, electrophoresis gel mobility shift assay (EMSA)
analysis for NF-
B-DNA binding was performed in control and
endrin-treated cells.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture and Differentiation.
3T3-L1 cells (Green and
Kehinde, 1974
) were obtained from American Type Culture Collection
(Rockville, MD). Passages 3 through 9 were used in all studies. Cells
were cultured in Dulbecco's modified Eagle's medium containing 10%
calf bovine serum. Confluent cells were induced to differentiate by
incubation for 48 h with differentiation medium containing 1 µM
dexamethasone, 0.2 mM 3-isobutyl-1-methylxanthine (IBMX), 10 µg/ml
insulin, and 10% FBS in Dulbecco's modified Eagle's medium. After
this time, cells were maintained in postdifferentiation medium
containing 10 µg/ml insulin and 10% FBS, and the medium was changed
every 2 days. To study the effects of some pesticides on
differentiation, different concentrations of the pesticides were added
along with the differentiation medium for 48 h. The same
concentration of the pesticides was maintained when the medium was
replaced. Pesticides, obtained from Polysciences (Niles, IL), were
prepared as 1000× stocks in ethanol. The same quantity of this solvent
was added to the control cell culture plates. Troglitazone was obtained
from Dr. Ohsumi (Sankyo Company, Tokyo, Japan).
Oil Red O Staining.
Eight or 10 days after the induction of
differentiation, cells were stained with Oil Red O according to Kasturi
and Joshi (1982)
. Briefly, cells were washed twice with PBS and fixed
with 10% formalin in PBS for 1 h; then they were washed an
additional three times with water and dried. Cells were stained with
Oil Red O [6 parts of saturated Oil Red O dye (0.6%) in isopropanol and 4 parts of water] for 15 min. Excess of stain was removed by
washing with 70% ethanol, and then stained cells were washed with
water. In some experiments, spectrophotometrical quantification of the
stain was performed by dissolving the stained oil droplets in the cell
monolayers with 4% Nonidet P-40 in isopropanol for 5 min. Then, the
absorbance was measured at 520 nm.
Preparation of Nuclear Extracts.
Nuclei were isolated from
3T3-L1 cells according to a slightly modified method of Dignam et al.
(1983)
. Briefly, cells were washed and scraped into PBS and then
centrifuged for 10 min at 1850g at 4°C. The cell pellets
were resuspended in 5 volumes of hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.2 mM
phenylmethylsulfonyl fluoride, and 0.5 mM dithiothreitol) and
centrifuged for 5 min at 1850g at 4°C. Then, the packed
cells were resuspended in 3 volumes of hypotonic buffer and allowed to
swell for 10 min on ice. After that, cells were homogenized with 10 strokes using a glass Dounce homogenizer and then centrifuged for 15 min at 3300g at 4°C. The pellets obtained were the nuclei. Nuclear extracts were prepared from these nuclei by a slight
modification of the method of Lavery and Schibler (1993)
. Pelleted
nuclei were resuspended in 1.1× extraction buffer (300 mM NaCl, 1 M
urea, 1% Nonidet P-40, 1 mM dithiothreitol, and 25 mM HEPES, pH 7.9), mixed vigorously by vortex, and incubated for 30 min on ice. The extracts were clarified by pelleting the insoluble debris through centrifugation at 15,000g for 20 min at 4°C in a
microfuge. The supernatants were adjusted to 10% glycerol and then
rapidly frozen in liquid nitrogen and stored at
80°C. Protein
concentration was determined as described by Bradford (1976)
.
Western Blot (Immunoblot) Analysis.
Twenty micrograms of
nuclear protein was fractionated by 10% SDS-polyacrylamide gel
electrophoresis and electrophoretically transferred to nitrocellulose
membranes. After transfer, Poinceau S staining was performed to ensure
equal loading of each sample. To block nonspecific binding membranes
were incubated in TBST (150 mM NaCl, 10 mM Tris, 0.09% Tween 20, pH
8.0) containing 10% milk for 1 h at room temperature. The blots
were then incubated in TBST containing 5% milk with primary antibody,
polyclonal anti-C/EBP
or anti-C/EBP
or anti-C/EBP
antiserum
(1:1000 dilution for anti-C/EBP
and anti-C/EBP
and 1:500 for
C/EBP
; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for 2 h.
After washing for three times with TBST, the membranes were incubated
in TBST containing 5% milk with secondary antibody (horseradish
peroxidase-conjugated donkey anti-rabbit; 1:2000, Amersham Life
Sciences, Arlington Heights, IL) for 1 h. After three washes with
TBST, the blots were developed by the enhanced chemiluminescence
detection system (Pierce, Rockford, IL) and visualized by exposure to
autoradiography film. Immunoblotting analyses for PPAR
were
performed in similar conditions using 30 µg of nuclear extracts.
Polyclonal anti-PPAR
antibody (1:500 dilution) and secondary
antibody, horseradish peroxidase-conjugated anti-goat IgG (1:3000) were
purchased from Santa Cruz Biotechnology, Inc.
Electrophoretic Mobility Shift Assays.
A double-stranded
oligonucleotide corresponding to the C/EBP binding site in the C/EBP
promoter (Christy et al., 1991
) or NF-
B response element
(Stratagene, La Jolla, CA) was end-labeled using
[
-32P]ATP (Amersham Life Sciences) and T4
polynucleotide kinase (Promega, Madison, WI) according to the standard
methods. Ten micrograms of nuclear extracts was incubated in a buffer
containing 25 mM HEPES, pH 7.9, 10% glycerol, and 0.5 mM
dithiothreitol, with 3 µg of poly[d(I-C)] (Boehringer Mannhein,
Indianapolis, IN) and 5 µg of acetylated BSA for 30 min at 4°C. A
100-fold excess of specific competitor was added to some samples. Then,
the radiolabeled double-stranded oligonucleotide (100,000 cpm) was
added and incubated for an additional 20 min at 4°C. For supershift
assay, the specific antibodies anti-C/EBPs (
,
, or
; from
Santa Cruz Biotechnology, Inc.) or combinations of them were added at
the end of the second incubation period, mixed gently, and incubated
for 20 min at 4°C. Oligonucleotide-C/EBP binding was determined by
electrophoresis in a nondenaturing 4% polyacrylamide gel at 150 to 200 V for 3 to 4 h at 4°C. Gels were dried for 2 h at 80°C
and exposed to X-ray film in the presence of an intensifying screen at
80°C.
Statistical Analysis. Data were evaluated statistically by one-way ANOVA followed by Fisher's PLSD test or Student's t test at the significant level of p < .05.
| |
Results |
|---|
|
|
|---|
Effect of Some Cyclodiene Pesticides on Cell Morphology During Adipocyte Differentiation. It is well known that 3T3-L1 preadipocytes are able to initiate their conversion to mature adipocytes after the addition to the incubation medium of the differentiation inducers dexamethasone, insulin, and isobutylmethylxantine in the presence of FBS for 48 h. During this differentiation process, cells start to exhibit the morphology of adipocytes, including intracellular accumulations of lipid droplets, which can be stained with Oil Red O.
To test the effects of several pesticides on the conversion of 3T3-L1 fibroblast to adipocytes, the xenobiotics were added to the culture medium at the same time of the differentiation inducers and incubated for 48 h. The same concentration of pesticide was added subsequently in 48-h intervals each time the medium was changed to a fresh one. Under these conditions, our results have shown that some cyclodiene pesticides are able to inhibit the adipocyte differentiation process, antagonizing the action of these inducers. Figure 1, top, shows plates of control and endrin-treated cells, at different concentrations, stained with Oil Red O 8 days after differentiation induction. As can be observed, endrin clearly induced a dose-dependent inhibition on adipocyte differentiation.
|
|
Effects of Time of Endrin Treatment on Adipocyte
Differentiation.
As previously indicated, the incubation of
confluent cells with differentiation inducers for 48 h initiates
the adipocyte differentiation program in this cell line. Some chemical
agents, such as retinoic acid, which is known to interfere with this
overall process, has been shown to be ineffective if they are added
after this critical initiation period (Schwarz et al., 1997
). To test whether the endrin effect on adipocyte differentiation depends on the
period of differentiation process in which pesticide is added, we
conducted an experiment in which endrin (10 and 30 µM) was added to
the incubation medium either 2 days before the addition of
differentiation medium (day
2), at the same time as the addition of
differentiation inducers (day 0), or 1, 2, or 4 days after the
differentiation medium. Results shown in Fig.
3 indicate that endrin effects on
adipocyte differentiation depend on the period of the time of addition.
Suppression of fat colonies was more pronounced when it was added
before or at the same time of the addition of differentiation medium.
When endrin was added 1 or 2 days after the addition of the
differentiation inducers, the inhibitory effect of endrin was not so
pronounced, especially in the case of day 2 experiment. However, the
addition of endrin to the medium 4 days after the initiation of
differentiation, even at 30 µM concentration, could not reverse the
differentiation process that was already initiated. In this case, the
range of differentiation of endrin-treated cells as estimated by Oil
Red O stain was the same as that found in control even though this pesticide was present for a long exposure period (data not shown).
|
Effect of Endrin on Cellular Levels of C/EBP Isoforms in
Differentiating 3T3-L1 Cells.
The important role of C/EBP proteins
in the transcriptional control of adipogenesis has been extensively
described (Lin and Lane, 1992
, 1994
; Yeh et al., 1995
; Wu et al.,
1996
). To determine whether endrin altered C/EBP proteins expression
during the differentiation, immunoblots on nuclear extracts of control
and pesticide-treated cells were performed. Figure
4A shows the representative Western blots
analyzing the effect of endrin on the three C/EBP proteins described
(C/EBP
, C/EBP
, and C/EBP
). The results of densitometric evaluation of Western blots from at least two independent experiments were summarized and are shown in Fig. 4B. The pattern of changes of
temporal expression of both translational C/EBP
proteins
(p42C/EBP
and
p30C/EBP
) in control cells is in close
agreement with the previous observations reported from this laboratory
(Liu et al., 1996
). Endrin treatment at 10 µM concentration induced a
significant decrease in the titer of both p42 and p30 C/EBP
proteins, starting from day 1 of treatment.
|
, two translational products are observed: the
C/EBP
isoform designated as liver activator protein and a
smaller-molecular-weight protein of 20 kDa. As described previously (Liu et al., 1996
isoforms presented high values at early stages of the differentiation process (1 and 2 days), and from day 4, C/EBP
protein levels start to decrease. Endrin treatment did not induce significant alterations in this temporal expression pattern of either of C/EBP
proteins. C/EBP
protein was also expressed at high levels during the 48-h induction period (days 1 and 2), and similar to what was observed with C/EBP
protein, endrin treatment did not modify C/EBP
cellular levels.
Previously, we showed that intracellular accumulation of fat droplets,
characteristic of the conversion to adipocytes, evaluated by Oil Red O
stain, was inhibited by endrin in a dose-dependent manner. Figure
5A shows that the inhibition of C/EBP
protein was also endrin concentration dependent. C/EBP
protein
levels were also determined after the treatment of cells with different concentrations of dieldrin and aldrin. As predicted from the previous results of Oil Red O testing, the treatment with 30 µM dieldrin caused a most significant decrease in the C/EBP
protein expression (Fig. 5B). In addition, as showed in Fig. 5C, a direct correlation between C/EBP
inhibition and the decrease in intracellular
accumulation of fat droplets after endrin and dieldrin treatment can be
observed.
|
EMSA on Effect of Endrin on DNA-Binding Capacities of C/EBP
Isoforms.
To determine whether the effect of endrin on C/EBPs also
includes changes in their capacity of binding to their specific
response element DNA, EMSA experiments were carried out. The
oligonucleotides used as the probe corresponded to the consensus
C/EBP-binding site sequence in the C/EBP
promoter, which is known to
bind with all of the three different C/EBP isoforms (C/EBP
,
C/EBP
, and C/EBP
). Nuclear extracts (10 µg) were prepared from
control and 10 µM endrin-treated cells at different stages of
differentiation process and subjected to EMSA. Figure
6A shows the effects of endrin on binding
capacity of C/EBP proteins to 32P-labeled C/EBP
response element oligonucleotide probe at different times during the
differentiation process. Lane 1 shows DNA-binding activity of C/EBPs in
3T3-L1 fibroblast. After the exposure of 3T3-L1 preadipocytes to the
adipogenic inducers for 1 or 2 days (lanes 2 and 4, respectively), a
heterogeneous group of C/EBP complexes with capacity to bind to their
DNA recognition sequences were observed. At days 4 and 8 after the
induction of differentiation, the quantity of these DNA-C/EBP complexes
was significantly higher (lanes 6 and 8). Endrin treatment (10 µM)
did not induce any detectable alteration in C/EBP binding capacities on
day 1 (lane 3 versus lane 2). A slight increase (lane 5 versus lane 4)
or an absence of effects (experiments not shown) in C/EBP-DNA complexes
in endrin-treated samples was observed on day 2. However,
pesticide-treated samples showed a significant decrease in DNA-binding
capacities of the C/EBP isoforms at days 4 and 8 after differentiation
induction (lane 7 versus lane 6 and lane 9 versus lane 8, respectively). Furthermore, at both day 4 and 8, this reduction in the
C/EBP binding capacity induced by endrin was mainly caused by a
dramatic decrease in the abundance of the upper band species of
DNA-C/EBP complexes.
|
,
, and
) are capable of
binding to the same consensus C/EBP binding site, supershift studies
were performed to identify the components of the C/EBP complexes
affected by endrin treatment. To supershift complexes, nuclear extracts
from both control and treated cells were incubated with specific
antibodies against either one of these three C/EBP isoforms (
,
,
or
) or in combination. Supershift analyses were carried out at day
4 after the induction of differentiation, and the results are shown in
Fig. 6B. Lanes 1 and 9 show the C/EBP-DNA complexes obtained without
the incubation with the antibodies in control and treated samples,
respectively, and the above-mentioned decrease induced by endrin on
binding capacity was measured against these standards.
Incubation of nuclear extracts with antibody against C/EBP
caused
the supershift of the upper species of C/EBP complexes, showing that
this corresponds to the oligonucleotide-C/EBP
complexes (Fig. 6B,
lane 2). In addition, C/EBP
binding capacity can be evaluated by
studying the gel shift profiles when the
and
C/EBP isoforms
have been removal by supershifting using specific antibodies (Fig. 6B,
lane 7). With regard to endrin effects, supershift studies on
pesticide-treated nuclear extracts showed that endrin treatment at day
4 induced a dramatic decrease of oligonucleotide-C/EBP
complex
abundance (Fig. 6B, lane 2 versus lane 10 and lane 7 versus lane 15).
In contrast, the DNA-binding of C/EBP
at day 4 did not show any
significant differences between control and endrin-treated samples
(e.g., Fig. 6B, lane 3 versus lane 11 in which C/EBP
complexes have
been supershifted by using antibody against C/EBP
; compare gel shift
profiles in lane 6 with lane 14 in which C/EBP
complexes can be
observed after
and
C/EBP isoforms have been supershifted).
With regard to C/EBP
binding capacity, supershift analysis in the
presence of its antibody gave the appearance that endrin induced a
slight increase in C/EBP
binding capacity after 4 days of treatment
(Fig. 6B, lane 4 versus lane 12). However, when DNA-C/EBP
complexes
were analyzed after removal of C/EBP
and C/EBP
with antibodies
against these isoforms, no clear-cut differences between control and
endrin-treated samples could be observed (Fig. 6B, lane 5 versus lane 13).
Incubation of nuclear extracts at the same time with antibody against
all three C/EBP isoforms (
,
, and
) caused a total removal of
C/EBP complexes because all of them were supershifted (Fig. 6B, lane 8 versus lane 16). As expected, when a 100-fold excess of a cold
oligonucleotide was used as competitor, all DNA-C/EBP complexes were
totally eliminated (Fig. 6B, lane 17).
Supershift studies performed at day 8 after the induction of
differentiation also confirmed that endrin caused a decrease in
C/EBP
-DNA binding without altering C/EBP
or
-DNA complexes (data not shown).
It appears to be safe to conclude that DNA-binding activity of C/EBP
is selectively affected by endrin treatment, causing a significant
decrease in the abundance of C/EBP
-DNA complexes. Because it has
been already shown that endrin induces a decrease in the intracellular
level of C/EBP
(Fig. 4A), such a decrease is likely caused by the
reduction of the titer of C/EBP
protein.
Effects of Endrin and Dieldrin on Expression of PPAR
Protein
Isoforms.
In recent years, many studies have demonstrated that in
addition to C/EBPs, PPAR
also plays a fundamental role in the
transcriptional control of adipogenesis (Tontonoz et al., 1995
). For
this reason, we tested the effects of endrin on PPAR
protein isoform
levels. Immunoblottings were performed in nuclear extracts from control and treated cells at early stages after the induction of
differentiation (1 and 2 days) because PPAR
is induced very early in
the differentiation of cultured adipocyte cell lines. As previously
described (Hu et al., 1996
), two closely spaced bands of PPAR
(
1,
lower band;
2, upper band) could be recognized in a Western blot
analysis (Fig. 7A). As expected, 3T3-L1
preadipocytes/fibroblasts did not express recognizable amounts of
PPAR
protein (Fig. 7A, lane 1). One day after the addition of
differentiation inducers, the two isoforms of PPAR
could be detected
in control samples (lane 2). At the same time, 10 µM endrin-treated
nuclear extracts showed a reduction in the expression of PPAR
protein in comparison to control cells (lane 3).
|
protein isoforms
increased significantly in control cells (lane 4). Also, an increase
can be observed in PPAR
levels in endrin-treated cells in comparison
to the levels after pesticide treatment at day 1 (lane 5). However,
PPAR
protein levels in endrin-treated samples at 2 days still stayed
considerably reduced in comparison to what was observed in control
samples (lane 4 versus lane 5). These endrin-induced reductions in
PPAR
protein isoform levels at early stages of differentiation
process could also be observed at day 4 of differentiation (data not shown).
Dieldrin effects on PPAR
protein expression were also tested in
nuclear extracts at day 6 of differentiation. Western blotting analysis
showed the ability of 30 µM dieldrin to reduce the cellular levels of
both isoforms of PPAR
protein (Fig. 7B).
Effects of Endrin and Dieldrin on NF-
B Activation.
The
effects of cyclodiene pesticides on NF-
B activation were determined
by EMSA analysis with the NF-
B probe containing its specific
DNA-response element. Figure 8A shows the
effects of 10 µM endrin treatment on NF-
B-DNA binding at different
days after the induction of differentiation. No significant differences were found in NF-
B-oligonucleotide complexes observed in nuclear extracts prepared from control and endrin-treated cells at days 1 and 2 (lane 2 versus 3 and lane 4 versus 5, respectively). At day 4 after the
induction of differentiation, a decrease in the abundance of the
NF-
B-DNA complexes was observed in control cells in comparison to
what was observed at day 1 and 2. However, in endrin-treated cells at
day 4, the NF-
B-oligonucleotide complexes remained almost at the
same level as at days 1 or 2 (lane 6 versus 7). On day 8, a dramatic
failure in NF-
B-DNA binding was observed in control extracts (lane
8), whereas in the endrin-treated cells, the abundance of the NF-
B
complexes was still significantly higher than that in control cells
(lane 9 versus 8), although a decrease in their binding levels was
noted. Figure 8B shows that the action of endrin on NF-
B at day 8 of
differentiation is dose dependent, and the highest abundance of
NF-
B-DNA complexes was found in cells treated with 30 µM endrin, a
dose that almost totally suppressed the adipocyte conversion process. A
similar increase in NF-
B-DNA binding was observed in cells treated
with an inhibitory dose of dieldrin (30 µM) in comparison to control
cells at day 6 after the induction of differentiation (Fig. 8C).
|
Effects of Troglitazone on Antiadipogenic Action of Endrin.
Troglitazone is an antidiabetic drug known to act as a ligand for
PPAR
. Like other thiazolidinediones, troglitazone has been shown to
induce adipocyte differentiation (Spiegelman, 1998
). We tested the
possible antagonistic effect of troglitazone on the actions of endrin.
The results clearly showed that endrin suppressed the process of
adipogenic transformation even in the presence of troglitazone (Fig.
9) at the dose known to cause a relevant
increase on the differentiation of the adipocytes.
|
| |
Discussion |
|---|
|
|
|---|
Adipocyte differentiation is a complex process that includes a
cascade of events triggered by the action of insulin, aided by a
cAMP-elevating agent and dexamethasone in the presence of FBS in the
case of 3T3-L1 cells. Although not all of the interacting pathways have
been totally elucidated, experts in this field generally acknowledge
two major nuclear factor families controlling the process of adipocyte
differentiation: C/EBPs and PPAR
. By far, C/EBP
appears to be a
critical and indispensable nuclear transcription factor triggering the
entire process of adipocyte differentiation (e.g., Lin and Lane, 1994
;
Yeh et al., 1995
). Several studies have provided evidence that this
transcription factor not only is required but also is sufficient to
trigger differentiation of preadipocytes in the absence of the cocktail
of differentiation inducers (Freytag et al., 1994
; Lin and Lane, 1994
).
In support of the above conclusion, the suppression of C/EBP
expression with antisense treatment caused inhibition of the terminal
adipocyte differentiation, which seems to indicate that the sustained
expression of C/EBP
is required (Lin and Lane, 1992
). This continued
expression of C/EBP
during the terminal differentiated state has
been attributed to an autoactivation of the transcription of its own
gene, which contains C/EBP binding site in its proximal promoter. Our
results showed that endrin specifically caused a dramatic decrease in C/EBP
-DNA binding, which otherwise would have activated the
transcription of many specific adipocyte genes, including the C/EBP
gene. In analogy to the blocking action of antisense oligonucleotide
against C/EBP
gene (Lin and Lane, 1992
), the alterations induced by
endrin on C/EBP
-mediated transcription should therefore be
sufficient to cause the suppression of the acquisition of the adipocyte
phenotype observed in the pesticide-treated cells. Prevention of
adipogenesis by other compounds such as TCDD and retinoic acid has also
been related to an antecedent inhibition of C/EBP
expression (Liu et
al., 1996
; Schwarz et al., 1997
).
On the other hand, because C/EBP
is activated at a relatively late
point of differentiation (days 3-4) in comparison to C/EBP
and
C/EBP
in 3T3-L1 cells, there have been some questions regarding the
leading role of the
isoform in this process. According to Yeh et
al. (1995)
, the
and
isoforms play an early preparatory roles in
the differentiation pathway, relaying the effects of dexamethasone and
cAMP to C/EBP
gene-protein expression, leading to the activation of
the
isoform. Thus, the main role of C/EBP
and C/EBP
is to
prime the activation of C/EBP
, which, in effect, "turns on the
battery" of many adipocyte-specific genes. Our results showed that
the pattern of expression of C/EBP
protein observed after IBMX
stimulation was similar in control and endrin-treated cells. Also,
endrin did not affect the levels of C/EBP
. The lack of alteration in
both C/EBP
and C/EBP
DNA binding suggests that cAMP and
glucocorticoids pathways are not direct targets of the actions of
endrin in 3T3-L1 differentiation process.
Endrin has been shown to be effective in preventing the adipocyte
differentiation process only when it is added during the 24 to 48 h of exposure of the preadipocytes to the differentiation medium. As in
the case of endrin, other drugs that are known to suppress the
adipocyte differentiation program, such as TCDD and retinoic acid, have
already also been shown to be ineffective if they are added after this
critical period (Phillips et al., 1995
; Xue et al., 1996
). Our data
suggest that 72 to 96 h after the induction of differentiation
process, cells must have reached a stage at which point they are firmly
committed to adipocyte differentiation.
To test the possibility that there could be another factor affected by
endrin at an earlier stage of differentiation, we focused our attention
on PPAR
. This receptor is also an important member of the nuclear
transcription factor/receptor family that is known to mediate
adipogenic signaling (Tontonoz et al., 1994
). The expression of PPAR
is known to antecede the induction of C/EBP
in the cascade of events
leading to adipocyte differentiation (reviewed by Tontonoz et al.,
1995
). Our results showed that endrin was able to inhibit the induction
of PPAR
proteins elicited by hormonal inducers at an early stage of
differentiation (days 1 and 2). TCDD, although it is known to mainly
affect C/EBPs, was also observed to prevent mRNA PPAR
expression
(Liu et al., 1996
). As for the recognition of this receptor action,
there is a family of chemical agents that are known to specifically
affect PPAR
, making it possible to recognize the role of this
specific pathway from others. Thiazolidinediones, which have been
developed as antidiabetic drugs, act as direct ligands for PPAR
, and
therefore, they cause a potent and effective stimulation of
adipogenesis (Lehmann et al., 1995
). Our data show that troglitazone,
one of the thiazolidinediones, however, did not significantly prevent
the inhibitory effects of endrin on adipocyte differentiation. This
fact clearly indicates that endrin is not acting like a direct
antagonist of PPAR
ligands because the treatment with even high
doses of PPAR
stimulants could not reverse its actions on
differentiation process.
Another possibility we considered is that NF-
B could be the key
component directly affected by endrin. NF-
B has shown to be
activated on treatment of cells with phorbol esters like TPA and
cytokines such as TNF
(Beg et al., 1993
). Both compounds are well
known to interfere with adipocyte differentiation process. The potent
inhibition of the adipocyte differentiation process induced by TNF
has been attributed to an antecedent inhibition of both PPAR
and
C/EBP
expression (Ron et al., 1992
; Zhang et al., 1996
). Little is
known, however, about the relationship between NF-
B and the factors
implicated in the regulation of the differentiation of the adipocytes.
It is worthy to note that the decrease in NF-
B activation observed
from day 4 after the induction of differentiation occurs about the same
time of the increase in the expression of C/EBP
protein as well as
with a rise in its binding to DNA. Furthermore, the inhibition of the
normal decrease of NF-
B-DNA complexes at days 4 and 8 induced by
endrin also occurs at the same time as the decrease in the expression
of C/EBP
and its binding to its response element observed in
pesticide-treated cells. These facts are indicative of the relationship
between these two nuclear transcription factors. It must be pointed
out, however, that NF-
B is known to be a negative regulator, unlike
C/EBP
or PPAR
, meaning that only its overexpression above the
constitutive level could cause inhibition of differentiation. In this
case, what we observed is the failure of endrin-affected cells to lower
its level from normal at the proper time. Such an observation points to
the possibility that the failure of NF-
B to down-regulate at days 4 and 8 in cells affected by endrin is not the cause for the inhibition
of differentiation but rather is the direct result of endrin-induced suppression of C/EBP
. Consistent with this idea, some research groups have demonstrated the existence of functional and physical associations between NF-
B and C/EBP family members (Stein et al.,
1993
). Moreover, it appears that these physical associations can result
in the synergistic transcriptional activation of a number of genes (Ray
and Ray, 1995
). It has also been suggested that the functional
interactions between C/EBP and NF-
B might profoundly affect cellular
growth control because the expression of C/EBP isoforms, particularly
the
isoform, could modify the ability of NF-
B to control
cellular proliferation (Stein et al., 1993
). Two pieces of evidence
further supporting this hypothesis are 1) the observation that
troglitazone could not antagonize the inhibitory action of endrin on
differentiation and 2) endrin did not cause direct down-regulation of
TNF
receptor in our preliminary studies (data not shown). These
results indicate that TNF
or any other proinflammatory cytokines
pathway whose actions are mediated by NF-
B and, in turn, antagonized
by thiazolidinediones (Ohsumi et al., 1994
) is not directly affected by endrin.
These data, as well as observations by others, clearly support our
hypothesis that the effect of endrin on C/EBP
itself is likely to be
sufficient to explain its inhibitory action on adipocyte differentiation, which is already known to be accompanied by changes in
a number of interactive systems, such as PPAR
and NF-
B, as explained above.
The key remaining question is, then, what is the direct cause for
endrin-induced suppression of C/EBP
. As for the possible mechanism
by which endrin causes suppression of insulin-induced rise in the titer
of C/EBP
, our current thinking is that its action to induce EGF-like
mitogenic signaling in 3T3-L1 cells, as in the case of TCDD, is the
most likely cause. Cyclodiene insecticides such dieldrin, aldrin,
chlordane analogs, and endrin have already been shown to increase PKC
activities (Bagchi et al., 1997
), to inhibit cell communication
(Tsushimoto et al., 1983
), and to mimic the epidermal growth factor in
both 3T3-F442A and 3T3-L1 cells in their action to block
insulin-induced rise in C/EBP
titer (Liu et al., manuscript in
preparation). Additionally, the action of endrin in this regard is very
similar to that of TCDD, which clearly acts in this manner by
activating the epidermal growth factor signaling pathway (Phillips et
al., 1995
; Liu et al., 1996
). It is well known that in many cell types,
cell proliferation and differentiation are two mutually exclusive
programs. Indeed, the increased growth factor signaling is already
known to cause inhibition of C/EBP
gene expression (Mischoulon et
al., 1992
). Certainly, additional confirmatory work would be needed,
however, to firmly establish the connection between the
pesticide-induced mitogenic signaling and their inhibitory action on
C/EBP
.
In summary, we clearly established that endrin causes selective
inhibition of the rise in the level of C/EBP
protein that accompanies the early commitment of 3T3-L1 cells to differentiate into
adipocytes. Such an effect of endrin is accompanied by shifts of
PPAR
and NF-
B levels, which are consistent with the expected consequence of the change in C/EBP
.
| |
Acknowledgment |
|---|
We thank Debra Dunlap for her technical support and her help in correction of the manuscript.
| |
Footnotes |
|---|
Received October 23, 1998; Accepted April 15, 1999
This work was supported by Research Grants ES03575 and ES05707 from the National Institute of Environmental Health Sciences, California Agricultural Experimental Station, Grant HHHERP from Hawaii Heptachlor Research and Education Foundation, and a postdoctoral fellowship from the Ministerio de Educación y Cultura of Spain (to M.J.M.-A.). A portion of this work was previously presented in the 37th Annual Meeting of the Society of Toxicology (Seattle, 1998).
Send reprint requests to: Dr. Fumio Matsumura, Department of Environmental Toxicology, University of California, Davis, CA 95616. E-mail: fmatsumura{at}ucdavis.edu
| |
Abbreviations |
|---|
TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin;
C/EBP, CCAAT
enhancer binding protein;
PPAR, peroxisome proliferator-activated
receptor;
IBMX, 3-isobutyl-1-methylxanthine;
PKC, protein kinase C;
EMSA, electrophoresis gel mobility shift assay;
TNF, tumor necrosis
factor;
NF-
B, nuclear factor-
B;
TPA, 12-O-tetradecanoylphorbol-13-acetate.
| |
References |
|---|
|
|
|---|
B
: A mechanism for NF-
B activation.
Mol Cell Biol
13:
3301-3310
promotes the adipogenic program in a variety of mouse fibroblastic cells.
Genes Dev
8:
1654-1663
.
Science (Wash DC)
274:
2100-2103
.
J Biol Chem
270:
12953-12956
) gene expression during hepatocyte proliferation in the regenerating liver and in culture.
Mol Cell Biol
12:
2553-2560
B and C/EBP binding sites.
DNA Cell Biol
14:
795-802[Medline].